What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Julie Clarke, Jennifer Laskey, Amanj Kurdi, Olivia Wu, Robert Jones, Hilary Glen, Marion Bennie

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Abstract

Objective: To identify what matters to clinicians and patients when discussing cancer medicines' impact on health-related quality of life (HRQoL). Methods: A framework of HRQoL domain/domain elements was developed, informed by analysis of published patient reported outcome measures (PROMs), applicable to prostate cancer. Using mixed methods (eDelphi, Nominal Group Technique and questionnaire), prostate cancer clinicians and patients attending prostate cancer clinics and support groups were asked which domains/domain elements would be important to them when discussing the impact prostate cancer medicines have on their HRQoL. Results: Twenty-one clinicians and 71 patients participated from the West of Scotland. Clinicians and patients identified 53/62 domain elements across seven domains as important, of which 32 (60%) were common to both groups. Clinicians placed more importance than patients on Mood & Emotion; in contrast, patients placed importance on a broader range of Symptoms & Side Effects, being informed about their care, and having effective healthcare professional collaboration. Conclusion: This study provides insight into the similarities and differences between what clinicians and patients think is important when discussing the impact of cancer medicines on HRQoL. Future research should involve exploring the potential for consistency of medicines PROMs across different cancer types to support patient-clinician communication and drive improvements in care.

Original languageEnglish
Pages (from-to)3141-3150
Number of pages10
JournalSupportive Care in Cancer
Volume30
Issue number4
Early online date8 Dec 2021
DOIs
Publication statusE-pub ahead of print - 8 Dec 2021

Keywords

  • patient reported outcomes
  • PROMs
  • prostate cancer
  • health-related quality of life
  • mixed methods
  • consensus methods

Fingerprint

Dive into the research topics of 'What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer'. Together they form a unique fingerprint.

Cite this